Claritev (CTEV) Gains from Investment Securities (2024 - 2026)

Claritev (CTEV) posted quarterly Gains from Investment Securities of -$256000.0 for Q2 2025, down 116.82% year-over-year from $1.5 million in Q2 2024, and up 12.93% quarter-over-quarter from -$294000.0 in Q1 2025.

Claritev (CTEV) Gains from Investment Securities (2024 - 2026) Analysis & Trends

Claritev's Gains from Investment Securities history runs 2 years deep, the most recent figure standing at -$256000.0 for Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn
10 Claritev 645.93 Mn 624.98 Mn 189.81 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.65 Mn
Mar 31, 2026 -1.65 Mn
Jun 30, 2025 -256,000.00
Jun 30, 2025 -256,000.00
Mar 31, 2025 -294,000.00
Mar 31, 2025 -294,000.00
Jun 30, 2024 1.52 Mn
Jun 30, 2024 1.52 Mn
Mar 31, 2024 1.58 Mn
Mar 31, 2024 1.58 Mn